adrenic acid has been researched along with Disease Models, Animal in 2 studies
adrenic acid: RN given refers to cpd without isomeric designation
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
Excerpt | Relevance | Reference |
---|---|---|
"The CDAHFD-fed db/db mice with hepatic steatosis, inflammation, mild fibrosis, obesity, and hypercholesterolemia displayed significantly higher hepatic and plasma levels of free adrenic acid (p < 0." | 7.85 | Adrenic acid as an inflammation enhancer in non-alcoholic fatty liver disease. ( Azuma, T; Horas H Nababan, S; Kawano, Y; Kobayashi, T; Nishiumi, S; Yoshida, M, 2017) |
"The CDAHFD-fed db/db mice with hepatic steatosis, inflammation, mild fibrosis, obesity, and hypercholesterolemia displayed significantly higher hepatic and plasma levels of free adrenic acid (p < 0." | 3.85 | Adrenic acid as an inflammation enhancer in non-alcoholic fatty liver disease. ( Azuma, T; Horas H Nababan, S; Kawano, Y; Kobayashi, T; Nishiumi, S; Yoshida, M, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Horas H Nababan, S | 1 |
Nishiumi, S | 1 |
Kawano, Y | 1 |
Kobayashi, T | 1 |
Yoshida, M | 1 |
Azuma, T | 1 |
Signorini, C | 1 |
Cardile, V | 1 |
Pannuzzo, G | 1 |
Graziano, ACE | 1 |
Durand, T | 1 |
Galano, JM | 1 |
Oger, C | 1 |
Leoncini, S | 1 |
Cortelazzo, A | 1 |
Lee, JC | 1 |
Hayek, J | 1 |
De Felice, C | 1 |
2 other studies available for adrenic acid and Disease Models, Animal
Article | Year |
---|---|
Adrenic acid as an inflammation enhancer in non-alcoholic fatty liver disease.
Topics: Adult; Animals; Cytokines; Disease Models, Animal; Disease Progression; Fatty Acids, Unsaturated; Fe | 2017 |
Increased isoprostanoid levels in brain from murine model of Krabbe disease - Relevance of isoprostanes, dihomo-isoprostanes and neuroprostanes to disease severity.
Topics: Animals; Disease Models, Animal; Docosahexaenoic Acids; Fatty Acids, Unsaturated; Galactosylceramida | 2019 |